L7|ESP® for Academic Research + NCI-Designated Cancer Centers

overcoming core challenges

NCI-designated cancer centers and academic research are often burdened with data management challenges, including fragmented systems, limited interoperability, and scalability issues. These obstacles hinder research progress, complicate clinical workflows, and delay effective patient care. To remain at the forefront of personalized cancer research and treatment, it is crucial to adopt solutions that streamline data integration, enhance collaboration, and ensure robust data analytics. According to the NIH, effective data sharing and management are essential for accelerating cancer treatment advancements and achieving better patient outcomes. Traditional data management systems are no longer adequate—they have become liabilities. L7|ESP is designed to address these critical issues, providing a unified platform that streamlines data integration, enhances collaboration, and delivers robust analytics capabilities.

L7|ESP is the transformative platform

L7 Allogeneic NK Cell Therapy Supply Chain Vf 3s new

Enhanced RESEARCH AND ACCELERATED DEVELOPMENT

L7|ESP revolutionizes research and development at cancer centers by providing a robust platform for seamless data integration and real-time analysis. Researchers can access and analyze diverse datasets, including genomic, proteomic, and clinical data, fostering a comprehensive understanding of cancer biology. This integration supports collaborative research efforts, accelerates the discovery of new biomarkers, and streamlines clinical trials. By leveraging advanced analytics and machine learning tools, L7|ESP transforms raw data into actionable insights, enabling researchers to identify patterns, predict outcomes, and develop innovative therapies more efficiently. The platform’s ability to manage complex data workflows ensures that research findings can be swiftly translated into clinical applications, accelerating the development of new treatments and improving patient outcomes. This holistic approach not only drives scientific breakthroughs but also enhances the overall efficiency and effectiveness of cancer research and development efforts.

STREAMLINED SUPPLY CHAIN MANAGEMENT

L7|ESP is a comprehensive solution for managing the entire supply chain, ensuring the smooth operation of both clinical and logistical processes. The platform efficiently manages incoming goods and raw materials, including receiving and tracking patient samples, blood samples, drug products, and inventory. L7|ESP provides real-time visibility into inventory levels, delivery schedules, and storage conditions, ensuring that all materials are handled appropriately and securely. The platform excels in managing outgoing products as well. L7|ESP ensures a clear chain of custody and chain of identity throughout the entire process so all materials and products can be traced back to their origins, maintaining integrity and compliance with regulatory standards. Additionally, L7|ESP supports clinical operations by streamlining the management of patient logistics, from sample collection to treatment delivery, enhancing the efficiency and reliability of clinical workflows.

OPTIMIZED MANUFACTURING AND RIGOROUS QC

L7|ESP significantly enhances the manufacturing and quality control processes at cancer centers by integrating data from various stages of production. This ensures that all data is accurately captured and accessible, facilitating better decision-making and process optimization. The platform supports the manufacturing of complex cellular therapies by providing real-time insights into production metrics, enabling timely interventions, and ensuring that products meet stringent regulatory standards. Additionally, L7|ESP’s robust quality control features monitor and manage the entire production process, ensuring that each batch adheres to the highest quality standards. By eliminating manual data entry and reducing the risk of errors, L7|ESP helps maintain high-quality standards, increases production efficiency, and ensures compliance with regulatory requirements.

REGULATORY Compliance

Compliance with regulatory standards is a critical concern for cancer centers and academic research institutions. L7|ESP addresses this challenge by offering robust compliance management features that ensure adherence to regulatory requirements. The platform provides comprehensive audit trails, real-time monitoring, and documentation capabilities that facilitate compliance with guidelines from agencies such as the FDA and NIH. By automating compliance processes and providing detailed reports, L7|ESP reduces the burden on staff and minimizes the risk of non-compliance. This focus on regulatory compliance ensures that cancer centers can conduct their research and clinical activities with confidence and integrity.

empowering Academic Research + NCI-Designated Cancer Centers with L7|ESP

L7|ESP empowers academic research and cancer centers to transform their data management practices, ensuring that they are not only data-rich but also information-efficient. Our platform provides a seamless integration of disparate systems, allowing for real-time data contextualization and workflow orchestration. By leveraging L7|ESP, they can eliminate data silos, reduce reliance on cumbersome paper records, and enhance their overall operational efficiency. Our solution supports regulatory compliance and offers advanced analytics to accelerate research and improve patient outcomes. L7|ESP stands out as the ideal choice for cancer centers looking to revolutionize their data management and research capabilities.

Streamlining Data Integration

Fragmented data systems create significant barriers to effective research, development, and manufacturing. L7|ESP resolves these issues by providing a comprehensive platform that unifies disparate data sources. This integration ensures that all relevant data—be it clinical, genomic, proteomic, or imaging—is easily accessible and interoperable across various departments and teams. By enabling real-time data updates and reducing errors associated with manual data handling, L7|ESP transforms fragmented data into a cohesive, reliable resource.

Enhancing Collaboration

Effective collaboration is essential for advancing cancer research and improving treatment outcomes. L7|ESP fosters a collaborative environment by providing a centralized platform where researchers, clinicians, and administrators can access and share data seamlessly. This unified approach breaks down silos, enabling teams to work together more efficiently on research projects, clinical trials, and patient care initiatives. L7|ESP’s user-friendly interface makes it easy for users to collaborate, ensuring that all team members have the information they need to make informed decisions.

Delivering Robust Analytics Capabilities

The ability to derive actionable insights from data is a critical component of modern cancer research and treatment. L7|ESP’s advanced analytics capabilities empower cancer centers to analyze large, complex datasets, identify patterns, and predict outcomes. The platform leverages machine learning and artificial intelligence to transform raw data into meaningful insights. These robust analytics tools enable researchers and clinicians to develop more effective treatment plans, accelerate the discovery of new therapies, and improve patient outcomes.

use case: research

Research is a cornerstone of the healthcare industry, driving advancements in medical knowledge and patient care. L7|ESP offers comprehensive support to cancer centers and research institutions, providing a unified platform for efficient data management, analysis, and collaboration. From conducting clinical trials to studying disease patterns and exploring innovative treatment approaches, L7|ESP streamlines the research process and empowers institutions to accelerate discoveries.

With L7|ESP, academic research + NCI-designated cancer centers can seamlessly integrate and organize diverse datasets from various sources, including genomics, proteomics, and clinical information. The platform’s advanced analytics tools enable researchers to uncover meaningful insights, identify correlations, and discover potential biomarkers. By facilitating collaboration and data sharing among multidisciplinary research teams, L7|ESP drives collaborative breakthroughs and enhances the translation of research findings into clinical practice.

L7|ESP empowers cancer centers and research institutions in their pursuit of groundbreaking discoveries. By offering a unified platform for data management, analysis, and collaboration, L7|ESP streamlines research processes and accelerates the translation of findings into clinical practice. With L7|ESP’s advanced analytics tools and seamless data integration, health systems can drive interdisciplinary collaboration, uncover meaningful insights, and make significant contributions to advancing medical knowledge and improving patient care.

supporting case studies

Connect with the L7 Team to find out more about the work we did with The Jackson Laboratory and WashU.

CONNECT

use case: advanced therapeutics

Academic research + NCI-designated cancer centers play a pivotal role in the development and delivery of advanced therapeutics, revolutionizing patient treatment options. L7|ESP supports them in this field by providing robust data management and analysis capabilities. From cell and gene therapies to immunotherapies, L7|ESP facilitates the complex data handling and processing required for advanced therapeutic research and implementation.

By integrating and analyzing diverse data types, such as genomics, patient outcomes, and treatment responses, L7|ESP empowers cancer centers and research institutions to identify biomarkers, predict treatment efficacy, and optimize therapeutic approaches. The platform’s customizable workflows and automated pipelines enhance the efficiency of advanced therapeutic development and manufacturing, enabling health systems to accelerate the translation of research into clinical applications.

L7|ESP empowers academic research + NCI-designated cancer centers to drive innovation and advancements in advanced therapeutics. By providing robust data management and analysis capabilities, L7|ESP enables health systems to integrate diverse datasets, identify biomarkers, and optimize therapeutic approaches. With L7|ESP’s customizable workflows and automated pipelines, health systems can streamline the development and manufacturing of advanced therapeutics, accelerating the translation of research into clinical applications. L7|ESP plays a pivotal role in the progress of health systems, empowering them to deliver cutting-edge therapies and improve patient outcomes.